Clinical Trial Update: A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) [Phase 1, Phase 2]

View source ↗

Summary

Two-part Phase 1/2 trial evaluating intravitreal Eye103 for safety and efficacy in diabetic macular edema and neovascular age-related macular degeneration; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• EYE103

Snippet

Sponsor: EyeBiotech Ltd. | Conditions: Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) | Phase 1, Phase 2 | Status: COMPLETED